Floatz logo

M-Sympathol

Hypotensive Disorder

The Second Affiliated Hospital of Dalian Medical UniversitySmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
89/ 100

Competitive context

1 Active assets in the Hypotensive Disorder cohort.

Asset / SponsorPhaseRating
Ephedrine, Anhydrous
University Hospital, Clermont-Ferrand
Phase 4BB
L-Bupivacaine
University Hospital Dubrava
Phase 4BB
Noradrenaline
The Second Affiliated Hospital of Dalian Medical University
Phase 3B
Imisopasem Manganese
MetaPhore Pharmaceuticals
Phase 1/2CCC
Marcaine
Ankara University
UnknownD
Midodrine
The Cleveland Clinic
N/AD
Fentanyl
Ankara University
UnknownD
Nitroglycerin Tablets
Liang Bing
N/ANR

Same molecule, other indications

M-Sympathol is also rated in:

carotid stenosisDormant
B
Indicative · Phase 4
63 / 100
View asset →
ischemic strokeActive
B
Indicative · Phase 3
56 / 100
View asset →
cognitive disorderDormant
B
Indicative · Phase 2/3
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →